The Conversation U.S. on Nostr: The price of asthma medication has soared in the U.S. over the past decade and a ...
Published at
2024-03-26 20:31:00Event JSON
{
"id": "3a8e62ebc59cc014e39d09007145a7c989ebbe0260f05a96b24c069d0d1e2316",
"pubkey": "ee9c46e5cc4022d8bd8cea507b03fee1ac0ac7ff8927eadee67254f170e91877",
"created_at": 1711485060,
"kind": 1,
"tags": [
[
"t",
"health"
],
[
"proxy",
"https://newsie.social/users/TheConversationUS/statuses/112163884918601031",
"activitypub"
]
],
"content": "The price of asthma medication has soared in the U.S. over the past decade and a half. \n\nThe pharmaceutical company Teva sells QVAR RediHaler, a corticosteroid inhaler, for $286 in the U.S.\n\nIn Germany, Teva sells that same inhaler for $9.\n\nhttps://theconversation.com/asthma-meds-have-become-shockingly-unaffordable-but-relief-may-be-on-the-way-222858 \n#health",
"sig": "d7a8e8389b4aa2daaa5db8e9d8bafd0a3e4da2493c735b133247c7a984cbb920565e86cc494c8beb6b3199c34f7e7c54497fd865e1f4e06f5f24164246495166"
}